Advances in the chemo‑preventive effects and mechanisms of ursolic acid against lung cancer (Review)
- PMID: 40747695
- PMCID: PMC12340665
- DOI: 10.3892/or.2025.8959
Advances in the chemo‑preventive effects and mechanisms of ursolic acid against lung cancer (Review)
Abstract
Ursolic acid (UA), a natural pentacyclic triterpenoid carboxylic acid, exhibits diverse biological activities and notable antitumor properties. Lung cancer (LC), a leading malignancy of the respiratory system, is predominantly classified into small cell LC and non‑small cell LC. The increasing incidence and mortality rates of LC have spurred considerable interest in the chemo‑preventive potential of UA. Accumulating evidence demonstrates that UA markedly inhibits LC cell proliferation and induces apoptosis. Mechanistically, UA induces cell cycle arrest at the G0/G1 phase, thereby suppressing LC cell invasion, migration and tumor growth. Furthermore, UA has shown synergistic effects when combined with other therapeutic agents, including mitotic kinase inhibitors and multifunctional nanomedicines, effectively overcoming drug resistance in LC cells. These multifaceted mechanisms collectively contribute to the chemo‑preventive efficacy of UA against LC. Consequently, UA represents a promising candidate for LC prevention and therapy. The present review comprehensively summarizes the anticancer effects and molecular mechanisms of UA in LC, offering insights to guide future research and facilitate the development of innovative therapeutic strategies.
Keywords: chemoprevention; lung cancer; phytomedicine; respiratory diseases; ursolic acid.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures





Similar articles
-
Cudratricusxanthone A exhibits antitumor activity and enhances chemosensitivity to cisplatin against NSCLC via targeting EGFR.Sci Rep. 2025 Aug 11;15(1):29425. doi: 10.1038/s41598-025-14889-x. Sci Rep. 2025. PMID: 40790077 Free PMC article.
-
Ursolic acid inhibits the formation of aberrant crypt foci and affects colonic sphingomyelin hydrolyzing enzymes in azoxymethane-treated rats.J Cancer Res Clin Oncol. 2008 Jan;134(1):101-7. doi: 10.1007/s00432-007-0255-4. Epub 2007 Jun 29. J Cancer Res Clin Oncol. 2008. PMID: 17605045 Free PMC article.
-
Ursolic acid suppresses triple-negative breast cancer progression through mediating FABP4/PPARG pathway.Eur J Med Res. 2025 Jul 2;30(1):550. doi: 10.1186/s40001-025-02794-y. Eur J Med Res. 2025. PMID: 40604951 Free PMC article.
-
Advances in antitumor activity and mechanism of natural steroidal saponins: A review of advances, challenges, and future prospects.Phytomedicine. 2024 Jun;128:155432. doi: 10.1016/j.phymed.2024.155432. Epub 2024 Feb 9. Phytomedicine. 2024. PMID: 38518645
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. - PubMed
-
- Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical